Education and Public Outreach
The Education and Public Outreach EPO’s mission is to reach out to kids and teenagers to make STEM attractive to them in a ludic, practic, integrated and team-oriented way. The ultimate goal is to estimulate their curiosity in STEM Education and facilitate significant experiences in teaching and learning. To do that, thorough our program ‘ECUSA in the Schools’, we (1) put together science fairs, workshops and talks, and (2) roll out educational projects and programs in schools and community centers across the United States, both in English and Spanish taught by scientists from Spain. In addition, at EPO we are aware of the educational gap in the United States, and we firmly believe in the social responsibility of taking those same workshops and programs free for girls, boys and teenagers in racialized and / or economically disadvantaged contexts such as a priority axis of action in reducing inequality of educational opportunities.
Contact: epo@ecusa.es
EPO Team

Cristina Sastre Reyero
Chair EPO
She studied biology at the Universitat Autònoma de Barcelona and did her internship at the assisted reproduction unit of the Hospital Universitari Vall d’Hebron. After graduating she moved to Madrid where she took a Master’s degree in molecular biomedicine at the Universidad Autónoma de Madrid and then began her doctoral studies at the Vascular Pathology Laboratory of the Instituto de Investigaciones Sanitarias of the Fundación Jiménez Díaz with a thesis on the inflammation of atherosclerotic plaque. In February 2016 she moved to Boston to start as a Postdoctoral Fellow in Dr. W. Taylor Kimberly’s neurology lab at Massachusetts General Hospital to investigate mechanisms of inflammation in stroke.

Olga Lancho Medina
Co-Chair EPO
PhD in Molecular Biosciences at Universidad Autonoma de Madrid. She performed her PhD studies at the Centro de Biologia Molecular Severo Ochoa, in Madrid, Spain. Currently, she is a postdoctoral researcher in the Rutgers University. Her research is focused on the study and characterization of new therapeutic targets to treat pediatric leukemias.